Insider trades
Richard S. Levy, Director of Madrigal Pharmaceuticals MDGL, has filed 2 purchases and 47 sales on the open market. Over the past 12 months that comes to a net sale of $7.4M. The latest trade was on 06/17.
Richard S. Levy
Director
- First filing
- 23/01/19
- Trades
- 116 trades
- Buys / sales
- 2 / 47
- 12-month net buying
- −$7.4M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MDGL | Open-market sale10b5-1 plan | 05/22 | 05/22 | 5,682 sh12 trades | $515.44avg. | $2,928,717.87 | −20.5% |
MDGL | Open-market sale10b5-1 plan | 25/11/13 | 25/11/14 | 8,500 sh14 trades | $520.96avg. | $4,428,193.06 | −28.6% |
| Open-market buyAmendment | 25/05/14 | 25/05/19 | 20,000 sh | $3.19 | $63,800 | +64.5% | |
| Open-market buy | 25/05/14 | 25/05/16 | 20,000 sh | $3.19 | $63,800 | +64.5% | |
| Open-market sale10b5-1 plan | 24/11/07 | 24/11/08 | 5,000 sh | $350.00 | $1,750,000 | −31.2% | |
MDGL | Open-market sale10b5-1 plan | 24/11/01 | 24/11/05 | 5,000 sh4 trades | $300.94avg. | $1,504,709 | −31.2% |
MDGL | Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 11,000 sh6 trades | $257.48avg. | $2,832,325.94 | −51.6% |
MDGL | Open-market sale | 23/01/17 | 23/01/19 | 22,489 sh10 trades | $293.15avg. | $6,592,685.55 | −71.2% |
